Tag: PTC Therapeutics

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to PTC Therapeutics

Duchenne Muscular Dystrophy Therapeutics Market 2022 with Top Countries Data Analysis ...

Added to Collection on: 2022-06-12 18:22:05

Tags for this article:

Life Sciences
Health sciences
Health care
Muscular dystrophy
Deflazacort
Glucocorticoids
Pregnanes
Prodrugs
Duchenne
PTC Therapeutics
Dystrophy
Sarepta Therapeutics

Click the tags to see associated articles and topics

View Article Details
No New Issues for Evrysdi Reported in Compassionate Use Program - SMA News Today

Added to Collection on: 2022-07-22 15:32:36

Tags for this article:

Neurological disorders
Branches of biology
Neurodegenerative disorders
Spinal muscular atrophy
Orphan drugs
Neurogenetic disorders
Motor neuron diseases
Risdiplam
SMA
Muscle atrophy
PTC Therapeutics
Germany

Click the tags to see associated articles and topics

View Article Details
PTC Therapeutics falls as partner Roche reports Q3 sales for SMA therapy - Seeking Alpha

Added to Collection on: 2022-10-18 18:10:02

Tags for this article:

Neurological disorders
Neurodegenerative disorders
Spinal muscular atrophy
RTT
OTC Markets Group
PTC Therapeutics
SMA Foundation

Click the tags to see associated articles and topics

View Article Details
Duchenne Muscular Dystrophy Market including top key players PTC Therapeutics

Added to Collection on: 2023-01-07 14:35:05

Tags for this article:

Life Sciences
Articles
Health
RTT
Biotechnology
Muscular dystrophy
BioMarin Pharmaceutical
Virotherapy
Sarepta Therapeutics
PTC Therapeutics
Duchenne
Deflazacort

Click the tags to see associated articles and topics

View Article Details
Analyst Reaffirms Positive Outlook on PTC Therapeutics with Adjusted Price Target

Added to Collection on: 2023-09-18 18:34:04

Tags for this article:

Valuation
Financial ratios
Financial analysts
Price?earnings ratio
PTC Therapeutics
Investment
Goldman Sachs

Click the tags to see associated articles and topics

View Article Details
PTC to sell spinal muscular atrophy drug royalties for $1B | BioPharma Dive

Added to Collection on: 2023-10-19 15:57:46

Tags for this article:

Biotechnology
PTC Therapeutics
South Plainfield, New Jersey
Royalty payment
Roche
Ataluren
royalty pharma

Click the tags to see associated articles and topics

View Article Details
CHMP Issues Negative Opinion for Renewal of Conditionally Approved Therapy Ataluren

Added to Collection on: 2024-01-31 20:12:20

Tags for this article:

Clinical research
Orphan drugs
Ataluren
Cystic fibrosis
Oxadiazoles
Duchenne muscular dystrophy
PTC Therapeutics
Nonsense mutation
Placebo

Click the tags to see associated articles and topics

View Article Details
FDA Nod in Duchenne Helps Wider Swath of Patients With the Rare Muscle Disease

Added to Collection on: 2024-03-22 16:51:13

Tags for this article:

Biotechnology
Muscular dystrophy
Rare diseases
Genetic engineering
Duchenne muscular dystrophy
Applied genetics
Deflazacort
Delandistrogene moxeparvovec
Gene therapy
PTC Therapeutics
Exon skipping
Sarepta Therapeutics

Click the tags to see associated articles and topics

View Article Details
Nike, Kura Sushi fall; Infinera, Protagonist Therapeutics rise, Friday, 6/28/2024

Added to Collection on: 2024-06-28 21:50:08

Tags for this article:

Biotechnology
PTC Therapeutics
South Plainfield, New Jersey
Duchenne

Click the tags to see associated articles and topics

View Article Details
Vanguard Group Inc. Buys 855,354 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT)

Added to Collection on: 2024-07-02 12:31:31

Tags for this article:

Equity securities
Stock market
Biotechnology
PTC Therapeutics
South Plainfield, New Jersey
PTC
Short
Stock
NASDAQ
Amgen
Share
Vanguard Group Inc.

Click the tags to see associated articles and topics

View Article Details